The ambitious '95-95 by 2025' roadmap for the diagnosis and management of fungal diseases.
about
The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations.Genetic susceptibility to severe asthma with fungal sensitization.Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision.Burden of Fungal Infections in Colombia.
P2860
The ambitious '95-95 by 2025' roadmap for the diagnosis and management of fungal diseases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
The ambitious '95-95 by 2025' ...... management of fungal diseases.
@en
The ambitious '95-95 by 2025' ...... management of fungal diseases.
@nl
type
label
The ambitious '95-95 by 2025' ...... management of fungal diseases.
@en
The ambitious '95-95 by 2025' ...... management of fungal diseases.
@nl
prefLabel
The ambitious '95-95 by 2025' ...... management of fungal diseases.
@en
The ambitious '95-95 by 2025' ...... management of fungal diseases.
@nl
P2860
P1433
P1476
The ambitious '95-95 by 2025' ...... management of fungal diseases.
@en
P2093
David W Denning
P2860
P304
P356
10.1136/THORAXJNL-2015-207305
P407
P577
2015-05-29T00:00:00Z